Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com.
- About AVPN
-
-
-
About AVPN
Who We Are
AVPN is the largest network of social investors in Asia. AVPN enables collaborations between policy makers, family offices, foundations and the private sector to increase the impact and flow of capital deployed towards closing SDG gaps in Asia.
AVPN is proud to be a CAF International Validated Organization. This badge reflects our commitment to transparency, accountability, and the highest standards of nonprofit operations.
Annual Review
AVPN has empowered its members to connect, learn, act, and lead in advancing social impact in Asia. Take a look at our interactive Annual Review to learn more about our work and impact.
-
-
-
- Members
-
-
-
Members
Membership Benefits
Unrestricted access to AVPN research reports and case studies
Access market-specific snapshots and opportunities
Increased visibility for events, programs and insights via AVPN website, blog, newsletters and social media channels
Leverage the AVPN platform to bring under-represented social issues top of mind for more than 700+ social investors
-
-
-
- Impact Areas
-
-
-
Impact Area
SIGNATURE THEMATIC PLATFORMS
SPECIAL INITIATIVES
Thematic Platforms
Driving Asian leadership in climate agenda by channeling more resources into climate action.
Mobilizing capital to improve outcomes for women and girls in Asia.
A collaborative space to scale policy action and implement solutions for health equity across Asia.
Equipping the next generation of Asian youths with the capital and resources they need to drive impactful change.
Special Initiatives
-
-
-
